Study: PET/CT can help NHL patients avoid unnecessary treatment

03/13/2008 | Medical News Today

PET/CT is a "more effective" way to evaluate radioimmunotherapy in non-Hodgkin lymphoma patients, says a news release from the University of Southern California. "Using this relatively novel hybrid imaging means that some patients will only require a one-day treatment of radioimmunotherapy instead of several rounds of chemotherapy," said one of the researchers.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC